Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2

Boris R.A. Blechacz, Rory L. Smoot, Steven F. Bronk, Nathan W. Werneburg, Alphonse E. Sirica, Gregory J. Gores

Research output: Contribution to journalArticlepeer-review

97 Scopus citations

Fingerprint Dive into the research topics of 'Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2'. Together they form a unique fingerprint.

Medicine & Life Sciences